Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers

International Journal of Oncology

Volumn 29, Issue 2, 2006, Pages 489-494

  Zagon, Ian S ^a   McLaughlin, Patricia J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Opioid growth factor receptor; Pancreatic cancer

Indexed keywords

METENKEPHALIN; METHIONINE ENKEPHALIN RECEPTOR; METHIONINE-ENKEPHALIN RECEPTOR; OPIATE RECEPTOR;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CANCER TRANSPLANTATION; CHEMISTRY; COLON TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE PROGRESSION; ENKEPHALIN, METHIONINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RECEPTORS, OPIOID;

EID: 36248988137     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.2.489     Document Type: Article

References (31)

1. Zagon IS, Hytrek SD and McLaughlin PJ: Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am J Physiol 271: R511-R518, 1996.
2. McLaughlin PJ, Zagon IS and Skitzki J: Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor. Int J Oncol 14: 373-380, 1999.
3. Zagon IS, Smith JP and McLaughlin PJ: Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 14: 577-584, 1999.
4. McLaughlin PJ, Levin RJ and Zagon IS: Regulation of human head and neck squamous cell carcinoma growth in tissue culture by the opioid growth factor. Int J Oncol 14: 991-998, 1999.
5. Bisignani GJ, McLaughlin PJ, Ordille SD, Jarowenko MJ and Zagon IS: Human renal cell proliferation in tissue culture is tonically inhibited by opioid growth factor. J Urol 162: 2186-2191, 1999.
6. 5]-enkephalin) prevents the incidence and retards the growth of human colon cancer. Am J Physiol 271: R780-R786, 1996.
7. Zagon IS, Hytrek SD, Smith JP and McLaughlin PJ: Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. Cancer Lett 112: 167-175, 1997.
8. McLaughlin PJ, Levin RJ and Zagon IS: Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice. Cancer Lett 199: 209-217, 2003.
9. McLaughlin PJ, Stack BC, Braine KM, Ruda JD and Zagon IS: Opioid growth factor (OGF) inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration. Int J Oncol 24: 227-232, 2004.
10. Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ and McLaughlin PJ: Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 17: 1053-1061, 2000.
11. Zagon IS and McLaughlin PJ: Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37: 79-88, 2003.
12. Zagon IS and McLaughlin PJ: Opioids and differentiation in human cancer cells. Neuropeptides 39: 495-505, 2005.
13. Zagon IS and McLaughlin PJ: Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. Int J Oncol 24: 1443-1448, 2004.
14. Cheng F, Zagon IS, Verderame MF and McLaughlin PJ: OGF-OGFr axis and its inhibitory actions on cell cycle progression of head and neck cancer cell line SCC1. Mol Biol Cell 16: 77, 2005.
15. Hytrek SD, Smith JP, McGarrity TJ, McLaughlin PJ, Lang CM and Zagon IS: Identification and characterization of the ζ-opioid receptor in human colon cancer. Am J Physiol 271: R115-R121, 1996.
16. Zagon IS, Smith JP, Conter R and McLaughlin PJ: Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. Int J Mol Med 5: 77-84, 2000.
17. McLaughlin PJ, Levin RJ and Zagon IS: The opioid growth factor receptor (OGFr) in human head and neck squamous cell carcinoma. Int J Mol Med 5: 191-196, 2000.
18. 5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 107: 335-339, 1997.
19. McLaughlin PJ, Stack BC, Levin RJ, Fedok F and Zagon IS: Defects in the OGF receptor (OGFr) in human squamous cell carcinoma of the head and neck. Cancer 97: 1701-1710, 2003.
20. Zagon IS, Ruth TB, Leure-DuPree AE, Sassani JW and McLaughlin PJ: Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. Brain Res 967: 37-47, 2003.
21. Zagon IS, Ruth TB and McLaughlin PJ: Nucleocytoplasmic distribution of opioid growth factor (OGF) and its receptor (OGFr) in tongue epithelium. Anat Rec 282: 24-37, 2005.
22. McLaughlin PJ and Zagon IS: Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor (OGFr). Int J Oncol 28: 1577-1583, 2006.
23. Yunis AA, Arimura GK, Russin DJ: Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer 19: 128-135, 1977.
24. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO and Chu TM: Characterization of a new primary human pancreatic tumor line. Cancer Invest 4: 15-23, 1986.
25. Kyriazis AA, Kyriasis AP, Sernberg CN, Sloane NH and Loveless JD: Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse. Cancer Invest 46: 5810-5815, 1986.
26. Fogh J and Trempe G: New human tumor cell lines. In: Human Tumor Cells In Vitro. Fogh J (ed). Plenum Press, New York, pp115-119, 1975.
27. Brattain MG, Fine WD, Khaled FM, Thompson J and Brattain DE: Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41: 1751-1756, 1981.
28. Shim WSN, Teh M, Mack POP and Ge R: Inhibition of angiopoietin-1 expression in tumor cells by antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice. Int J Cancer 94: 6-15, 2001.
29. Jaglowski JR, Zagon IS, Stack BC, Verderame MF, Leure-DuPree AE, Manning JD and McLaughlin PJ: Opioid growth factor (OGF) enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 56: 97-104, 2005.
30. Hytrek SD, McLaughlin PJ, Lang CM, and Zagon IS: Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone. Cancer Lett 101: 159-164, 1996.
31. Smith JP, Ahmad M, Conter R, Bingaman S, Harvey H, Mauger D, Demers L, McLaughlin PJ, Stanley W and Zagon IS: Treatment of advanced pancreatic cancer with opioid growth factor. Anticancer Drugs 15: 203-209, 2004.